Article Text
Abstract
It is argued here that bioethicists might inadvertently be promoting genetic determinism: the idea that genes alone determine human traits and behaviours. Discussions about genetic testing are used to exemplify how they might be doing so. Quite often bioethicists use clinical cases to support particular moral obligations or rights as if these cases were representative of the kind of information we can acquire about human diseases through genetic testing, when they are not. On other occasions, the clinical cases are presented in simplistic ways that portray genetic testing as yielding information more accurate than it actually is. It is concluded that, because of the problematic implications that the ideology of genetic determinism might have for individuals’ wellbeing and for our public policies, bioethicists should be careful to present these issues in ways that do not promote questionable ideas about the causal role of genes in human diseases and behaviours.
- BAPP, beta-amyloid precursor protein
- APOE, apolipoprotein E
- Bioethics
- genetic determinism
- genetic information
- genetic testing
Statistics from Altmetric.com
Footnotes
Read the full text or download the PDF:
Other content recommended for you
- The complexities of predictive genetic testing
- Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK
- The new genetics: Psychological responses to genetic testing
- Personal utility in genomic testing: is there such a thing?
- An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling
- Genetic testing for inherited breast and ovarian cancer syndromes: important concepts for the primary care physician
- Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries
- Genetic testing in hereditary non-polyposis colorectal cancer families with a MSH2, MLH1, or MSH6 mutation
- Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap
- Promises and perils of using genetic tests to predict risk of disease